Preliminary results have been obtained on the second phase of the clinical trials for the Normogen preparation. Stabilization of the tumor process with positive dynamics was observed for 80% of the patients who have various types of cancerous diseases.
details >     


At present clinical trials of the Normogen drug are carried out by the Kazakh Scientific Research Institute of Oncology and Radiology.

details >     


Report of Kazakhstan Scientific and Research Institute of Oncology and Radiology of the 1st phase of clinical trial of immunobiological, antitumoral drug Normogen
details >     
eXTReMe Tracker

10.07.2006
Report of Kazakhstan Scientific and Research Institute of Oncology and Radiology of the 1st phase of clinical trial of immunobiological, antitumoral drug "Normogen"


01.10.2004
Report of Kazakhstan Scientific and Research Institute of Oncology and Radiology on the experimental studies of antitumoral effect and toxicity of the immunological drug "Normogen".

14.05.2004
The scientific work of Kazakhstan scientists, "The use of anti-idiotypic antibodies to alfa-fetoprotein for decomposition of changed cells", was recognized as the best one at the Second World-Wide Congress on Immunology and Allergy.
















































   
2005 (c) Copyright Real Med Company. Все права защищены.